Re: Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the reduction by dutasteride of prostate cancer events study

T. Feng; L. E. Howard; A. C. Vidal; D. M. Moreira; R. Castro-Santamaria; G. L. Andriole; S. J. Freedland

doi:10.1111/iju.13265

Re: Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the reduction by dutasteride of prostate cancer events study

T. Feng
, L. E. Howard
, A. C. Vidal
, D. M. Moreira
, R. Castro-Santamaria
, G. L. Andriole
, S. J. Freedland

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	635
Number of pages	1
Journal	Journal of Urology
Volume	202
Issue number	4
DOIs	https://doi.org/10.1111/iju.13265
State	Published - Oct 2019

Access to Document

10.1111/iju.13265

Cite this

@article{89535c4f55f64f34be9fede37e05a2f9,

title = "Re: Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the reduction by dutasteride of prostate cancer events study",

author = "T. Feng and Howard, \{L. E.\} and Vidal, \{A. C.\} and Moreira, \{D. M.\} and R. Castro-Santamaria and Andriole, \{G. L.\} and Freedland, \{S. J.\}",

year = "2019",

month = oct,

doi = "10.1111/iju.13265",

language = "English",

volume = "202",

pages = "635",

journal = "Journal of Urology",

issn = "0022-5347",

number = "4",

}

TY - JOUR

T1 - Re

T2 - Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the reduction by dutasteride of prostate cancer events study

AU - Feng, T.

AU - Howard, L. E.

AU - Vidal, A. C.

AU - Moreira, D. M.

AU - Castro-Santamaria, R.

AU - Andriole, G. L.

AU - Freedland, S. J.

PY - 2019/10

Y1 - 2019/10

UR - https://www.scopus.com/pages/publications/85095599558

U2 - 10.1111/iju.13265

DO - 10.1111/iju.13265

M3 - Comment/debate

C2 - 31766083

AN - SCOPUS:85095599558

SN - 0022-5347

VL - 202

SP - 635

JO - Journal of Urology

JF - Journal of Urology

IS - 4

ER -

Re: Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the reduction by dutasteride of prostate cancer events study

Access to Document

Other files and links

Cite this